Company
Saol Therapeutics
Privately held, clinical-stage pharma focused on CNS disorders and orphan diseases.
Also known as Saol Therapeutics Inc.
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Founded
- 2015
- Employees
- nearly 100 employeesSource (opens in a new tab)
- Legal name
- Saol Therapeutics Inc.
- saolrx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Saol Therapeutics (pronounced "Sail") is a privately held, clinical-stage, pharmaceutical company with operations in Roswell, GA, Dublin, Ireland and Hamilton, Bermuda. Saol is focused on late-stage clinical development in CNS disorders such as pain and spasticity, and orphan diseases.
Funding snapshot
- Total raised
- $115MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $115M2026-09-15
Funding rounds
- Strategic Investment
- $115M2026-09-15, Company stated
Loading relationship preview